Compare KMPR & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KMPR | ITGR |
|---|---|---|
| Founded | 1990 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | N/A | 2000 |
| Metric | KMPR | ITGR |
|---|---|---|
| Price | $41.28 | $72.79 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 8 |
| Target Price | $56.67 | ★ $93.71 |
| AVG Volume (30 Days) | ★ 854.1K | 585.3K |
| Earning Date | 11-05-2025 | 10-23-2025 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.89 | 2.42 |
| Revenue | ★ $4,845,500,000.00 | $1,831,074,000.00 |
| Revenue This Year | N/A | $9.58 |
| Revenue Next Year | $4.52 | N/A |
| P/E Ratio | ★ $10.61 | $29.89 |
| Revenue Growth | 4.45 | ★ 9.54 |
| 52 Week Low | $33.91 | $62.00 |
| 52 Week High | $72.25 | $146.36 |
| Indicator | KMPR | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 53.68 | 50.43 |
| Support Level | $38.51 | $69.12 |
| Resistance Level | $41.58 | $73.49 |
| Average True Range (ATR) | 0.94 | 1.61 |
| MACD | 0.51 | 1.06 |
| Stochastic Oscillator | 90.61 | 85.81 |
Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.